Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival

Ocular Oncology

Optimising prediction of early metastasis-free survival in uveal melanoma using a four-category model incorporating gene expression profile and tumour size

Br J Ophthalmol

Roelofs KA, Grewal P, Lapere S, Larocque M, Murtha A, Weis E

doi: 10.1136/bjophthalmol-2020-317714

Ocular Oncology

Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014

JAMA Ophthalmol.

Rajeshuni N, Zubair T, Ludwig CA, Moshfeghi DM, Mruthyunjaya P

doi: 10.1001/jamaophthalmol.2020.2254.

Ocular Oncology

Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D

Ophthalmology.

Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL

doi: 10.1016/j.ophtha.2019.04.027.

UveitisFurther Publications

Adding TCGA chromosome classes to AJCC system allows for more precise prognostication in uveal melanoma patients

Ophthalmology

Gelmi MC, Bas Z, Malkani K, Ganguly A, Shields CL, Jager MJ

doi: 10.1016/j.ophtha.2021.11.018

Ocular Oncology

A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Br J Ophthalmol.

Binkley E, Triozzi PL, Rybicki L, Achberger S, Aldrich W, Singh A

doi: 10.1136/bjophthalmol-2019-314461.

Ocular Oncology

Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients

Invest Ophthalmol Vis Sci.

Drabarek W, Yavuzyigitoglu S, Obulkasim A, van Riet J, Smit KN, van Poppelen NM, Vaarwater J, Brands T, Eussen B, Verdijk RM, Naus NC, Mensink HW, Paridaens D, Boersma E, van de Werken HJG, Kilic E, de Klein A, for the Rotterdam Ocular Melanoma Study Group.

doi: 10.1167/iovs.18-24818.

Ocular Oncology

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma

Am J Ophthalmol.

Cai L, Paez-Escamilla M, Walter SD, Tarlan B, Decatur CL, Perez BM, Harbour JW

doi: 10.1016/j.ajo.2018.07.045.

Ocular Oncology

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations

JAMA Ophthalmol.

Durante MA, Walter SD, Paez-Escamilla M, Tokarev J, Decatur CL, Dubovy SR, Schefler AC, Harbour JW

doi: 10.1001/jamaophthalmol.

Ocular Oncology

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Eur J Cancer.

Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C

doi: 10.1016/j.ejca.2017.05.038.

Related content

Optimising prediction of early metastasis-free survival in uveal melanoma using a four-category model incorporating gene expression profile and tumour size

Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014

Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D

Adding TCGA chromosome classes to AJCC system allows for more precise prognostication in uveal melanoma patients

A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition